Biotechnology

Longevity Health

Longevity Health released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 425.86K, actual EPS USD -0.8295

Longevity Health released FY2025 9 Months Earnings on November 14 (EST), actual revenue USD 1.44 M, actual EPS USD -3.9081

Longevity Health released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 503.61K, actual EPS USD -1.5592

Longevity Health released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 1.014 M, actual EPS USD -3.0806

Longevity Health Holdings Merges with THPlasma

Longevity Health Extends Due Diligence Deadline for Merger with 20/20 Biolabs

Longevity Health Holdings Completes ATM Stock Issuance and Announces Merger Plan

Longevity Health Holdings Merges with 20/20 Biolabs and Lists on NASDAQ

Longevity Health Holdings and 20/20 BioLabs Reach Merger Agreement

Longevity Health released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 510.35K, actual EPS USD -1.5192

Longevity Health released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 17.48 K, actual EPS USD -1.3122

Longevity Health released FY2024 Annual Earnings on March 31 (EST), actual revenue USD 50.32 K, actual EPS USD -14.5603

Longevity Health released FY2023 9 Months Earnings on November 14 (EST), with actual revenue of USD 0 and EPS of USD -225.77

Longevity Health released FY2024 9 Months Earnings on November 14 (EST), actual revenue USD 32.84K, actual EPS USD -13.194

Longevity Health released FY2023 Q3 earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -18.5415

Longevity Health released FY2024 Q3 earnings on November 14 EST, actual revenue USD 20.52K, actual EPS USD -4.1307

Longevity Health released FY2024 Semi-Annual earnings on August 14 (EST), actual revenue USD 12.32K, actual EPS USD -9.0384

Longevity Health released FY2024 Q2 earnings on August 14 (EST), actual revenue USD 12.32 K, actual EPS USD -4.781

Longevity Health released FY2023 Q2 earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -150.0367

Longevity Health released FY2023 Semi-Annual earnings on August 14, 2024 (EST) with actual revenue of USD 0 and EPS of USD -206.7395

Envirotech Vehicles

Lulus Fashion Lounge

Wheels Up Experience

Biodesix

Ohmyhome

Ping An Biomedical

Bark

Beam Therapeutics

SILVER PEGASUS ACQUISITION CORP COM USD0.0001 CL A (SUB/RTS) 26/06/2030

PELICAN ACQUISITION CORPORATION SHS USD0.0001(S/R 02/05/2030)

ADMA生物制藥

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel制藥

OpGen

福泰制藥

再生元制藥

阿里拉姆制藥

Argenx

百濟神州

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Longevity Health(XAGE.US)